Literature DB >> 9988170

Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure.

T H Roels1, A S Bloom, J Buffington, G L Muhungu, W R Mac Kenzie, A S Khan, R Ndambi, D L Noah, H R Rolka, C J Peters, T G Ksiazek.   

Abstract

In 1995, 316 people became ill with Ebola hemorrhagic fever (EHF) in Kikwit, Democratic Republic of the Congo. The exposure source was not reported for 55 patients (17%) at the start of this investigation, and it remained unknown for 12 patients after extensive epidemiologic evaluation. Both admission to a hospital and visiting a person with fever and bleeding were risk factors associated with infection. Nineteen patients appeared to have been exposed while visiting someone with suspected EHF, although they did not provide care. Fourteen of the 19 reported touching the patient with suspected EHF; 5 reported that they had no physical contact. Although close contact while caring for an infected person was probably the major route of transmission in this and previous EHF outbreaks, the virus may have been transmitted by touch, droplet, airborne particle, or fomite; thus, expansion of the use of barrier techniques to include casual contacts might prevent or mitigate future epidemics.

Entities:  

Mesh:

Year:  1999        PMID: 9988170     DOI: 10.1086/514286

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  58 in total

1.  Ebola virus transmission in guinea pigs.

Authors:  Gary Wong; Xiangguo Qiu; Jason S Richardson; Todd Cutts; Brad Collignon; Jason Gren; Jenna Aviles; Carissa Embury-Hyatt; Gary P Kobinger
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Understanding the dynamics of Ebola epidemics.

Authors:  J Legrand; R F Grais; P Y Boelle; A J Valleron; A Flahault
Journal:  Epidemiol Infect       Date:  2006-09-26       Impact factor: 2.451

3.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 4.  What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? The Importance of Bridging Studies and Species-Independent Correlates of Protection.

Authors:  Hana Golding; Surender Khurana; Marina Zaitseva
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 5.  Progress in filovirus vaccine development: evaluating the potential for clinical use.

Authors:  Darryl Falzarano; Thomas W Geisbert; Heinz Feldmann
Journal:  Expert Rev Vaccines       Date:  2011-01       Impact factor: 5.217

6.  Modeling spatial invasion of Ebola in West Africa.

Authors:  Jeremy P D'Silva; Marisa C Eisenberg
Journal:  J Theor Biol       Date:  2017-05-24       Impact factor: 2.691

7.  Strategies for containing Ebola in West Africa.

Authors:  Abhishek Pandey; Katherine E Atkins; Jan Medlock; Natasha Wenzel; Jeffrey P Townsend; James E Childs; Tolbert G Nyenswah; Martial L Ndeffo-Mbah; Alison P Galvani
Journal:  Science       Date:  2014-10-30       Impact factor: 47.728

8.  Ebola: Implications and Perspectives.

Authors:  Carlos Del Rio; Jeannette Guarner
Journal:  Trans Am Clin Climatol Assoc       Date:  2015

Review 9.  Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection.

Authors:  Natalie E Dean; M Elizabeth Halloran; Yang Yang; Ira M Longini
Journal:  Clin Infect Dis       Date:  2016-02-29       Impact factor: 9.079

Review 10.  Considerations for use of Ebola vaccine during an emergency response.

Authors:  Jenny A Walldorf; Emily A Cloessner; Terri B Hyde; Adam MacNeil
Journal:  Vaccine       Date:  2017-09-07       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.